Edition:
United States

Zimmer Biomet Holdings Inc (ZBH.N)

ZBH.N on New York Stock Exchange

111.76USD
22 Jun 2018
Change (% chg)

$0.25 (+0.22%)
Prev Close
$111.51
Open
$111.50
Day's High
$112.82
Day's Low
$110.84
Volume
721,626
Avg. Vol
276,630
52-wk High
$133.45
52-wk Low
$104.28

Chart for

About

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $22,717.60
Shares Outstanding(Mil.): 203.27
Dividend: 0.24
Yield (%): 0.86

Financials

  ZBH.N Industry Sector
P/E (TTM): 54.79 41.24 33.54
EPS (TTM): 2.04 -- --
ROI: 1.74 14.38 13.09
ROE: 3.80 17.60 15.10

BRIEF-Zimmer Biomet Holdings Announces 510(K) Clearance For Zyston Strut Open Titanium Interbody Spacer System

* ZIMMER BIOMET HOLDINGS ANNOUNCES 510(K) CLEARANCE FOR ZYSTON STRUT OPEN TITANIUM INTERBODY SPACER SYSTEM Source text for Eikon: Further company coverage:

May 22 2018

BRIEF-Zimmer Biomet Reports Q1 Earnings Per Share $0.85

* ZIMMER BIOMET ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 26 2018

BRIEF-Zimmer Biomet Announces FDA Clearance And First Surgical Case Of The Persona Trabecular Metal Tibia

* ZIMMER BIOMET ANNOUNCES FDA CLEARANCE AND FIRST SURGICAL CASE OF THE PERSONA® TRABECULAR METAL™ TIBIA

Apr 16 2018

BRIEF-Zimmer Biomet Says CEO Hanson's FY'17 Total Compensation Was $16.3 Mln

* ZIMMER BIOMET SAYS CEO BRYAN HANSON'S FY 2017 TOTAL COMPENSATION WAS $16.3 MLN - SEC FILING

Apr 02 2018

Zimmer beats knee implant bellwether case on appeal

A Pepsi bottling plant worker has lost his bid to revive a lawsuit claiming Zimmer Biomet Holdings Inc failed to warn that its NexGen knee implants were prone to premature loosening in patients who engage in activities that need knee flexibility.

Mar 09 2018

BRIEF-Zimmer Biomet Holdings Files For Offering Of Floating Rate Notes Due 2021

* ZIMMER BIOMET HOLDINGS INC - FILES FOR OFFERING OF FLOATING RATE NOTES DUE 2021 AND NOTES DUE 2023 - SEC FILING Source text: (http://bit.ly/2tzlxYD) Further company coverage:

Mar 08 2018

BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16

* ZIMMER BIOMET ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS

Jan 30 2018

BRIEF-Zimmer Biomet Holdings Announces FDA Clearance Of Sidus Stem-Free Shoulder System

* ZIMMER BIOMET HOLDINGS SAYS THE SIDUS SYSTEM WILL BE AVAILABLE IN U.S BEGINNING IN Q1 OF 2018 Source text for Eikon: Further company coverage:

Jan 03 2018

Competitors

Earnings vs. Estimates